European Respiratory Society International Congress, Madrid 29 September 2019

Dr Steve Pawsey, CMO at NeRRe Therapeutics presents a poster at the European Respiratory Society, Madrid 29 September 2019 entitled : “The neurokinin-1 receptor antagonist orvepitant improves chronic cough symptoms: results from a Phase 2b trial”
ers-2019-poster

NeRRe Therapeutics Announces Publication of Positive Results in a Phase 2 Pilot Study of Orvepitant in Chronic Refractory CoughNews
Dr Mary Kerr, CEO of NeRRe Therapeutics to Present at Biotech Showcase in San Francisco on 13 January 2020News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.